Highlights SUNE BIOP OTC Markets

Equities

SBFM

US8677812054

Delayed OTC Markets Other stock markets 11:15:16 2021-10-05 am EDT			5-day change	1st Jan Change
0.1175 ^USD	-1.26%		+0.34%	+657.96%

Apr. 19	Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	MT
Apr. 19	Top Premarket Decliners	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	Apr. 19	MT
Top Premarket Decliners	Apr. 19	MT
Sunshine Biopharma Shares Slump After Reverse Stock Split Announcement	Apr. 12	MT
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	Mar. 28	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	Nov. 13	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Jewish General Hospital Announces Termination of the Research Agreement with Sunshine Biopharma, Inc	Nov. 02	CI
Sunshine Biopharma Gets Extension to Comply With Nasdaq Minimum Bid Price Rule	23-09-22	MT
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	23-08-10	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	23-05-10	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-04	CI
Sunshine Biopharma, Inc. Signs Exclusive Worldwide License with University of Arizona for PLpro-Based Covid-19 Treatment	23-02-28	CI
Sunshine Biopharma Signs Research Agreement with the Jewish General Hospital to Advance the Development of Adva-27A Anticancer Compound	23-02-10	CI
Sunshine Biopharma Signs Research Agreement with the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound	23-02-10	CI
Sunshine Biopharma Launches $2 Million Share Buyback Program; Shares Down Pre-Bell	23-01-19	MT
Sunshine Biopharma, Inc. announces an Equity Buyback for $2 million worth of its shares.	23-01-19	CI
Sunshine Biopharma, Inc. authorizes a Buyback Plan.	23-01-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights SUNE BIOP OTC Markets

Equities

SBFM

US8677812054

Highlights

Filters